ICD-10-CM Billable Code

C81.1

Nodular sclerosis Hodgkin lymphoma

Clinical Classification Guidelines

Inclusion Terms

  • Nodular sclerosis classical Hodgkin lymphoma

Medical Intelligence & Overview

Nodular sclerosis Hodgkin lymphoma is a specific type of Hodgkin lymphoma, a cancer that originates in the lymphatic system. This form is characterized by the presence of large, abnormal lymphocytes called Reed-Sternberg cells within lymph nodes. It is the most common subtype of classical Hodgkin lymphoma, particularly affecting young adults and adolescents. The term 'nodular sclerosis' refers to the pattern of tissue scarring and nodules seen in affected lymph nodes, which helps in identifying this lymphoma under microscopic examination. Recognizing this condition is crucial for timely diagnosis and treatment, with positive outcomes often achieved through modern therapies.

Causes & Symptoms

Clinical Causes: Genetic factors may increase susceptibility to Hodgkin lymphoma. Previous viral infections, particularly Epstein-Barr virus (EBV), have been associated with its development. Environmental exposures, such as exposure to certain chemicals, might play a role, though this link is less clear. Family history of Hodgkin or other lymphomas can increase risk.

Key Symptoms: Painless swelling of lymph nodes, often in the neck, armpits, or groin. Unexplained weight loss. Persistent fever that is not due to infection. Night sweats, especially severe enough to soak clothing or bedding. Fatigue and general feeling of weakness. Itching skin without an apparent cause. Less commonly, symptoms may include cough or chest pain if mediastinal lymph nodes are involved.

Diagnostic & Treatment

Diagnosis Path: To diagnose nodular sclerosis Hodgkin lymphoma, healthcare providers typically follow a sequence of steps, including: - Physical examination to identify swollen lymph nodes. - Imaging tests such as CT scans or PET scans to determine the extent and location of involvement. - Lymph node biopsy, where a sample is taken for microscopic examination. Under the microscope, pathologists look for Reed-Sternberg cells and characteristic tissue patterns. - Additional blood tests may support the diagnosis, check overall health, and assess organ function. - Sometimes, bone marrow biopsies are performed to evaluate disease spread. - The overall assessment helps classify the stage of the disease, which guides treatment options.

Treatment Protocols: Treatment strategies for nodular sclerosis Hodgkin lymphoma often involve a combination of therapies tailored to the disease stage and patient's overall health. Common approaches include: - Chemotherapy: Using drugs to kill or control cancer cells, often with protocols like ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine). - Radiation therapy: Targeted radiation may be applied to affected areas to eliminate remaining cancer cells. - Stem cell transplantation: In cases of relapse or refractory disease, high-dose chemotherapy followed by stem cell transplant might be considered. - Supportive care: Managing symptoms and side effects of treatment, including infections, nutritional support, and mental health resources. The prognosis for nodular sclerosis Hodgkin lymphoma is generally favorable, especially when diagnosed early and treated appropriately.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.1 a billable ICD-10 code?
Yes, C81.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.1?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma and any associated comorbidities for accurate reporting.

Cite this Clinical Reference